Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Specific Leukocyte Count Predicts Bacteremia

By LabMedica International staff writers
Posted on 24 Nov 2010
A decrease in the absolute number of lymphocytes in a white blood cell (WBC) count is thought to be an indicator that the patient may have a bacterial infection in the blood. More...


Similarly, the neutrophil-lymphocyte count ratio (NLCR) has been shown as a simple promising method to evaluate systemic inflammation in critically ill patients. These two parameters may be better than conventional infection markers in an emergency care unit.

In a retrospective study carried out at the emergency department (ED) of the Jeroen Bosch Hospital, (Hertogenbosch; The Netherlands) examined consecutive patient records from adult patients (18 years or older) admitted to the ED over a seven month period from April to October 2005, with suspected community-acquired bacteremia. C-reactive protein (CRP) level, WBC count, neutrophil count, lymphocyte count, and NLCR were compared between 92 patients with positive blood cultures and an equal number of age and gender matched patients with negative blood cultures.

CRP levels were measured with a fully automated enzyme-linked immunoassay using an Aeroset 2.0 analyzer (Abbott Diagnostics; Santa Clara, CA, USA). WBC, neutrophil and lymphocyte counts were determined on a Sysmex XE-2100 hematology analyzer (Sysmex Corporation; Kobe, Japan). Significant differences between patients with positive and negative blood cultures were detected with respect to CRP level (176 ± 138 mg/L versus 116 ± 103 mg/L; lymphocyte count (0.8 ± 0.5 × 109/L versus 1.2 ± 0.7 × 109/L; and NLCR (20.9 ± 13.3 versus 13.2 ± 14.1). However, there were no significant differences regarding WBC count and neutrophil count. Sensitivity, specificity, positive and negative predictive values were highest for the NLCR (77.2%, 63.0%, 67.6% and 73.4%, respectively).

Culturing microorganisms is the most definitive way to confirm bacterial infections. Unfortunately, this gold standard is time consuming and may be influenced by several factors including previous antibiotic usage. The authors concluded that, "Absolute lymphocytopenia can be used in the prediction of infectious emergency admissions. Moreover, the ratio of neutrophil and lymphocyte counts (NLCR) has even higher value in predicting bacteremia. This marker is simple, easily obtained and calculated, easy to integrate in daily practice and without extra costs.” The study was published on October 29, 2010, in the journal Critical Care.

Related Links:

Jeroen Bosch Hospital
Abbott Diagnostics
Sysmex Corporation




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Slide Scanner System
NanoZoomer S540MD
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.